Loading...
Guest User
Welcome! Please login.
| IPO Listing At | BSE SME |
| SME IPO Issue Type | Fixed Price Issue |
| Total Issue Size | ₹20.62 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹20.62 Cr |
| Fresh Issue | ₹19.58 Cr |
| Face Value | ₹10 Per Equity Share |
| Issue Price | ₹54.00 per share |
| Discount | Retail: 0.00,Employee: 0.00,ShareHolder: 0.00 |
| BSE Code | 544365 |
| Registrar | Integrated Registry Management Services... |
| Lead Managers |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 2,000 shares and in multiples thereof
Incorporated in 2020, Shanmuga Hospital Limited is a Multispecialty Hospital.
Shanmuga Hospital is equipped with advanced healthcare technology and having 151 bed capacity, it addresses the community’s medical needs, serving patients from nearby regions.
Accredited by NABH and NABL, the hospital is dedicated to providing high-quality healthcare services, including prevention, treatment, and rehabilitation.
Located at 51/24 Saradha College Road, Salem, Tamil Nadu, the hospital spans 45,311 square feet across two blocks and three floors, offering IPD and OPD services with a dedicated team.
Hospital Units:
Services: Oncology, General Surgery, Orthopaedics, Cardiology,General Medicine, Paediatrics & Neonatology, Neurology, Endocrinology & Diabetes Department, Plastic Surgery, Respiratory Medicine.
As on August 31, 2024, the hospital had 72 doctors, out of whom 9 doctors were Resident Doctors, 7 Junior Doctors, 28 Senior Consulting Doctors and 28 Consulting Visiting Doctors.
Competitive Strengths:
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding Capital Expenditure towards Purchase of additional Medical Equipment | 14.53 |
| 2 | General Corporate Expenses | 3.83 |
| 3 | Issue Expenses | 2.26 |
| Total | 20.62 |
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 36.53 | 33.92 | 23.05 | 10.65 |
| Total Income | 24.83 | 43.39 | 39.50 | 41.47 |
| Profit After Tax | 2.39 | 5.26 | 4.76 | 6.72 |
| NET Worth | 19.53 | 17.13 | 11.82 | 7.06 |
| Reserves and Surplus | 9.73 | 7.34 | 11.74 | 6.98 |
| Total Borrowing | 9.76 | 9.02 | 7.65 | |
| Amount in ₹ Crore | ||||
| KPI | Mar 31, 2024 |
|---|---|
| ROE | 30.71% |
| ROCE | 35.89% |
| Debt / Equity | 0.53% |
| RoNW | 30.71% |
| PAT Margin | 12.13% |
| Price to Book Value | 3.09 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 5.37 | 4.75 |
| P/E (x) | 10.05 | 11.36 |
| Promoter Holding | 100% | 71.95% |
| Market Cap | ₹73.51 Cr. | |
